Clinical Trials for Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer

Find clinical trials for advanced her2 negative breast carcinoma hrd+breast cancer. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer

NCT ID: NCT05656131

This clinical trial is studying the effectiveness and safety of a treatment called fluzoparib, both on its own and in combination with another drug called camrelizumab, for women with advanced brea...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions